CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 404 enrolled
Drug / intervention
PCM +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01401101
NCT01401101Phase 2Completed

Improving PTSD Management in Primary Care

RAND·interventional·Posted Jul 25, 2011·Updated Sep 2, 2016

In Brief

A Phase 2 clinical trial evaluating PCM and MEU for Stress Disorders, Post-Traumatic. Completed, enrolled 404 participants across 7 sites.

Detailed Summary

The purpose of this study is to conduct a randomized trial of a Post Traumatic Stress Disorder (PTSD) Care Management (PCM) program to detect, treat, and improve PTSD treatment processes and outcomes in patients seeking primary care from FQHCs and evaluate its effectiveness on improving the processes and outcomes of care for PTSD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 25, 2011
Enrollment StartJun 1, 2010
Primary CompletionFeb 1, 2014
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 14.9 years ago

Interventions

PCMother

Care Manager (CM) intervention

MEUother

The MEU condition consists of only the clinician education and patient screening without written feedback.